Healthcare utilization and costs among prolactinoma patients: a cross-sectional study and analysis of determinants.
Merel van der MeulenAmir H Z NajafabadiDaniel J LobattoWilbert B van den HoutCornelie D AndelaIngrid M ZandbergenAlberto M PereiraWouter R van FurthThea P M Vliet VlielandNienke R BiermaszPublished in: Pituitary (2020)
Healthcare utilization and costs of prolactinoma patients are related to patient-reported HRQoL, bother by disease and needs for support. Therefore, addressing patients' HRQoL and needs is a way forward to improve efficiency of care and patients' health status.